The recognition of PAMPs during intra-amniotic infection (e.g., chorioamnionitis) leads to up-regulation of TLRs (Kim et al., 2004) and release of pro-inflammatory IL-1β from immune cells. This evidence concerns the gene IL1B and chorioamnionitis.